Financials data is unavailable for this security.
Inc stmt in AUDIncome statement in AUD
Year on year
Cochlear Ltd grew revenues 22.14% from 925.63m to 1.13bn while net income improved 29.54% from 145.84m to 188.92m.
|Net profit margin||17.46%|
|Return on assets||21.62%|
|Return on equity||45.68%|
|Return on investment||32.81%|
Cash flow in AUD
Cochlear Ltd did not generate a significant amount of cash. However, the company earned 185.11m from its operations for a Cash Flow Margin of 16.37%. In addition the company used 50.13m on investing activities and also paid 130.89m in financing cash flows.
|Cash flow per share||4.17|
|Price/Cash flow per share||33.45|
|Book value per share||8.53|
|Tangible book value per share||4.82|
Balance sheet in AUD
|Total debt/total equity||0.3546|
|Total debt/total capital||0.2618|
Growth rates in AUD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 21.05% and 29.51%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
|Div yield(5 year avg)||3.24%|
|Div growth rate (5 year)||0.44%|
|Payout ratio (TTM)||69.59%|
|EPS growth(5 years)||0.8695|
|EPS (TTM) vs |
TTM 1 year ago